KALM Therapeutics, Inc. — Form D
KALM Therapeutics, Inc. of HUNTSVILLE, AL, a company, filed a Form D exempt-offering notice with the SEC on 2024-08-09. The offering totals $590K, of which $590K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-08-09
- Form: D
- Accession: 0002032945-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $590K
- Amount sold: $590K
- Minimum investment: $25K
- Investors: 14
- Date of first sale: 2024-07-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-521126
Issuer
- Name: KALM Therapeutics, Inc.
- CIK: 0002032945
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 6820 MOQUIN DRIVE NW, HUNTSVILLE, AL, 35806
- Phone: (256) 715-9336
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Chris Seibert | Director | Huntsville, AL |
| Anuj Singhal | Director | Huntsville, AL |
| Chris Seibert | Executive Officer | Huntsville, AL |
| Anuj Singhal | Executive Officer | Huntsville, AL |
More